Finance

Lists
Why is 12X1 down 5.86%?
Dive Deeper
12X1:FRA
Anavex Life Sciences Corp
€1.12
-5.86%
(-0.070) 1D
Oct 19, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 12X1...
Open
€1.10
High
€1.12
Low
€0.94
Mkt. cap
115.87M
Avg. vol.
106.00
Volume
50.00
52-wk high
€8.14
52-wk low
€0.94
No. of employees
34
Open
€1.10
High
€1.12
Low
€0.94
Mkt. cap
115.87M
Avg. vol.
106.00
Volume
50.00
52-wk high
€8.14
52-wk low
€0.94
No. of employees
34
News stories
From web sources and news partners
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteanavex.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.28M
4.62M
4.16M
-4.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.55M
2.13M
2.29M
-2.03M
Operating expense
10.83M
6.75M
6.46M
-6.77M
Total operating expenses
10.83M
6.75M
6.46M
-6.77M
Operating income
-10.83M
-6.75M
-6.46M
6.77M
Other non operating income
-
-
-
-
EBT including unusual items
-9.83M
-5.66M
-5.34M
7.82M
EBT excluding unusual items
-9.83M
-5.66M
-5.34M
7.82M
Income tax expense
-
18.00K
-
-
Effective tax rate
-
-0.32%
-
-
Other operating expenses
-
-
-
-
Net income
-9.83M
-5.68M
-5.34M
7.82M
Net profit margin
-
-
-
-
Earnings per share
-0.11
-0.06
-0.06
0.08
Interest and investment income
999.00K
1.08M
1.06M
1.07M
Interest expense
-
-
-
-
Net interest expenses
999.00K
1.08M
1.06M
1.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps